Table 1 Clinical and laboratory characteristics of patients and controls.

From: Localization of lipopolysaccharide from Escherichia Coli into human atherosclerotic plaque

  Controls (n = 15) Patients (n = 10) p
Age 70.7 ± 6.0 73.1 ± 8.9 0.433
Women (%) 26.7 20.0 0.702
Hypertension (%) 100.0 100.0
Dyslipidaemia (%) 90 90
Diabetes (%) 53.3 30.0 0.414
BMI (Kg/m2) 28.2 ± 2.7 27.1 ± 2.6 0.458
ACE/ARBs (%) 86.7 70.0 0.358
Β-blockers (%) 33.3 10.0 0.345
Antiplatelet drugs (%) 100.0 100.0
Statins (%) 100.0 90.0 0.400
Serum LPS (pg/ml) 43.5 ± 11.9 79.0 ± 10.7 <0.001
Serum zonulin (ng/ml) 2.2 ± 1.1 4.5 ± 0.7 <0.001